首页> 外文期刊>Acta clinica Croatica >SEXUAL ACTIVITY IN PATIENTS WITH CARDIAC DISEASES
【24h】

SEXUAL ACTIVITY IN PATIENTS WITH CARDIAC DISEASES

机译:心脏病患者的性活动

获取原文
获取原文并翻译 | 示例
           

摘要

In this article, we outline the latest guidelines published by the American I kart Association on sexual activity in patients with coronary artery disease, heart failure, structural heart diseases, arrhythmias, implanted pacemakers or cardioverter defibrillators, as well as on treatment options of sexual dysfunction. Sexual activities are similar to mild/moderate physical activity during a short period. Most patients are recommended to involve in sexual activity after prior comprehensive evaluation of physical condition.lhose with stable cardiac symptoms and good functional capacity are at a low risk of adverse cardiovascular events, and others require treatment or stabilization before involving in sexual activity. Stress testing is useful in evaluating safety of sexual activity in patients with questionable or undetermined risk. Treatment of sexual dysfunction includes counseling of patients and their sexual partners, and drug treatment with phosphodiesterase inhibitors (sildenafil, tadalafil, vardenafil) which have been demonstrated to be safe and effective, in men, and with serotonin reuptake inhibitors (flibanserin) and local vaginal estrogen administration in women. In conclusion, in routine clinical practice, patients should be approached individually and multidisciplinarily in order to detect and eliminate the factors that interfere with normal sexual activities and disturb the quality of life.
机译:在本文中,我们概述了美国冠心病患者冠状动脉疾病,心力衰竭,结构性心脏病,心律失常,植入的起搏器或心脏病患者的性活动患者的最新指南,以及性功能障碍的治疗方案。在短时间内,性活动类似于轻度/中度的体力活动。大多数患者建议在先前综合评估物理条件后涉及性活动。具有稳定的心脏症状和良好的功能能力较低的心血管事件的风险低,并且在涉及性活动之前需要治疗或稳定性。压力测试可用于评估可疑或未确定风险的患者的性活动安全性。性功能障碍的治疗包括患者及其性伴侣的咨询,并用磷酸二酯酶抑制剂(Sildenafil,Tadalafil,Vardenafil)的药物治疗已经证明是安全有效的男性和血清素再摄取抑制剂(Flibanserin)和局部阴道雌激素给妇女中的雌激素给药。总之,在常规临床实践中,患者应单独和多学科接触,以检测和消除干扰正常性活动并扰乱生活质量的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号